John G Ullman & Associates Inc Laboratory Corp Of America Holdings Transaction History

John G Ullman & Associates Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$197.69 - $227.29 $1,581 - $1,818	8 Added 0.34%	2,332 $530,000
Q3 2023 Nov 01, 2023	SELL	$201.05 - $221.7 $40,210 - $44,340	-200 Reduced 7.92%	2,324 $467,000
Q2 2022 Jul 27, 2022	SELL	$213.86 - $277.87 $641 - $833	-3 Reduced 0.12%	2,524 $592,000
Q1 2022 Apr 29, 2022	BUY	$259.82 - $298.18 $259 - $298	1 Added 0.04%	2,527 $666,000
Q4 2021 Jan 26, 2022	BUY	$271.6 - $314.21 $543 - $628	2 Added 0.08%	2,526 $794,000
Q3 2021 Nov 02, 2021	SELL	$274.82 - $308.34 $54,964 - $61,667	-200 Reduced 7.34%	2,524 $710,000
Q2 2021 Jul 23, 2021	SELL	$251.87 - $278.14 $23,172 - $25,588	-92 Reduced 3.27%	2,724 $751,000
Q1 2021 Apr 22, 2021	BUY	$204.88 - $255.03 $18,848 - $23,462	92 Added 3.38%	2,816 $718,000
Q4 2020 Feb 05, 2021	SELL	$186.91 - $214.42 $18,691 - $21,442	-100 Reduced 3.54%	2,724 $554,000
Q3 2019 Oct 21, 2019	SELL	$159.77 - $178.1 $63,908 - $71,240	-400 Reduced 12.41%	2,824 $474,000
Q2 2019 Aug 02, 2019	SELL	$144.16 - $172.9 $19,317 - $23,168	-134 Reduced 3.99%	3,224 $557,000
Q1 2019 Apr 30, 2019	BUY	$123.7 - $156.3 $76,199 - $96,280	616 Added 22.47%	3,358 $514,000
Q4 2018 Jan 29, 2019	SELL	$120.82 - $174.09 $337,329 - $486,059	-2,792 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$149.47 - $160.56 $417,320 - $448,283	2,792	2,792 $422,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on John G Ullman & Associates Inc with notifications on news.